Spectrum Solutions, LLC today announced the FDA Emergency Use Authorization (EUA) approval for the immediate use of saliva in COVID-19 testing exclusively using the Spectrum SDNA-1000 saliva collection device which has been proven to protect and preserve RNA used for the detection of infection.
Khrysos Industries, Inc. owned subsidiary of Youngevity International, Inc., announced today that the company has begun producing hand sanitizer in various sizes including 2 oz., 4 oz., 8 oz., and 1 Gallon Packaging.
Clarify Health, a leader in healthcare analytics, announced today that it launched two new critical applications in response to the needs of customers at the forefront of providing care to the communities impacted by COVID-19.
Nuclein LLC announces plans to expedite the commercialization of its Nuclein™ Hand-Held PCR Test.
The Feinstein Institutes for Medical Research, the research arm of Northwell Health, announced today the enrollment of three clinical trials in the ongoing effort to combat COVID-19, the novel coronavirus.
Hologic, Inc. announced today that the U.S. Food and Drug Administration (FDA) has granted Emergency Use Authorization (EUA) for the Company’s new Panther Fusion® SARS-CoV-2 assay, a molecular diagnostic test that detects SARS-CoV-2, the virus that causes COVID-19 disease.
Integrated DNA Technologies (IDT), a leading comprehensive genomics solutions provider, today announced its success in large-scale manufacturing of a key component used to enable testing of millions of Americans for COVID-19.
Sumitomo Heavy Industries, Ltd. has performed clinical trial of the BNCT system using an accelerator, targeting carcinoma of the head and neck region in collaboration with STELLA PHARMA CORPORATION (President: Tomoyuki Asano).
APLIX today announced the commercialization of new inter-mold® low profile hooks for medical and orthopedic applications. The inter-mold® technology is a breakthrough patented one-step injection molding solution which allows the creation of hooks directly into plastic parts.
CardioFocus, Inc., a medical device company dedicated to advancing ablation treatment for atrial fibrillation (AFib), today announced that the company has submitted a pre-market approval (PMA) supplement to the U.S. Food and Drug Administration (FDA) for the HeartLight X3 Endoscopic Ablation System for the treatment of AFib.